VALEO PHARMA ANNOUNCES UPSIZE OF PREVIOUSLY ANNOUNCED BOUGHT DEAL PRIVATE PLACEMENT OF CONVERTIBLE DEBENTURES TO $15 MILLION WITH CONCURRENT $10 MILLION PRIVATE PLACEMENT FROM INVESTISSEMENT QUEBEC

VALEO PHARMA ANNOUNCES UPSIZE OF PREVIOUSLY ANNOUNCED BOUGHT DEAL PRIVATE PLACEMENT OF CONVERTIBLE DEBENTURES TO $15 MILLION WITH CONCURRENT $10 MILLION PRIVATE PLACEMENT FROM INVESTISSEMENT QUEBEC

MONTREAL, QUEBEC, November 24, 2021 – Valeo Pharma Inc. (CSE:VPH, OTCQB: VPHIF, FSE: VP2) (“Valeo Pharma” or the “Company”), a Canadian pharmaceutical company, is pleased to announce that in connection with its previously announced bought deal private placement of...